Autolus Therapeutics (Autolus Therapeutics) Accumulated Depreciation : $-30.33 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Autolus Therapeutics's quarterly accumulated depreciation declined from Sep. 2023 ($-29.02 Mil) to Dec. 2023 ($-28.77 Mil) but then increased from Dec. 2023 ($-28.77 Mil) to Mar. 2024 ($-30.33 Mil).

Autolus Therapeutics's annual accumulated depreciation increased from Dec. 2021 ($-22.72 Mil) to Dec. 2022 ($-25.65 Mil) and increased from Dec. 2022 ($-25.65 Mil) to Dec. 2023 ($-28.77 Mil).

Autolus Therapeutics Accumulated Depreciation Historical Data

The historical data trend for Autolus Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autolus Therapeutics Accumulated Depreciation Chart

Autolus Therapeutics Annual Data

Trend

Sep16

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-8.57

-14.66

-22.72

-25.65

-28.77

Autolus Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-26.82	-28.98	-29.02	-28.77	-30.33

Autolus Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Autolus Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Autolus Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Autolus Therapeutics (Autolus Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (NAS:AUTL) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

6A3A:Germany

Address

191 Wood Lane, The MediaWorks, London, GBR, W12 7FP

Website

https://www.autolus.com

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.